Compound ID | 446
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Similar activity against E. coli and B. fragilis compared to cefdinir |
| Description: | 1. Inoue E, Nakane T and Mitsuhashi S. In vitro antibacterial activity and β-lactamase stability of E1101, a new Cephalosporin. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 119 2. Mikamo H, Kawazoe K, Izumi K, et al. Efficacy of a new oral Cephalosporin E1101 in the newly designed uterine endometritis model. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 120. |
| Institute where first reported: | Eisai Co. Ltd, Japan |
| Year first mentioned: | 1994 |
| Highest developmental phase: | Phase 2 |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9690119 |
| Citation: |